iCo Therapeutics Inc. announced that at its annual general meeting held on June 29, 2017 approved the election of Andrew Rae, Susan Koppy, Wiiliam Jarosz and Michael Liggett as directors of the Company and will hold office until the next annual general meeting of shareholders.